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fd. Note - This overview was originally presented at the 
International Symposium on Clinical Disorders of Bone 
and Mineral Metabolism, May 9-13, 1983. 
Earlier presentations and discussions at this Symposium 
left many questions unanswered about the optimal man-
agement of patients with primary hyperparathyroidism 
(PHPT) in whom the hypercalcemia is minimal and in 
whom signs and symptoms directly referable to hyper-
calcemia and/or HPT are lacking. Al though this condi-
tion has often been referred to as "asymptomatic PHPT", 
this term has been deliberately excluded from this paper 
because many patients with mild HPT are not truly 
asymptomatic. Clinically, their symptoms cannot be 
readily recognized, unlike the symptoms of PHPT, and 
the clinician cannot predict which of the many com-
plaints might be alleviated by "correct ive" surgery (1). 
With this in mind, a workshop was held to discuss a 
prospective study of the management of PHPT. Gener-
ally, everyone agreed that the current literature on PHPT 
does not provide adequate answers about optimal man-
agement of patients with mild PHPT. Few studies have 
addressed this issue, and only one is randomized and 
prospective (2). Although documentation exists that a 
skilled surgeon can correct hypercalcemia due to PHPT 
in more than 95% of patients (Wells, et al, pp. 152 ff.), 
little evidence exists that this is of short- or long-term 
benefit in mild diseases. In fact, there is a paucity of 
information about the benefits of surgery in patients with 
any degree of hypercalcemia (Posen, et al, pp. 154 ff.). 
Answers to many of these questions could be provided 
by a well-designed, prospective, randomized clinical 
trial to evaluate the benefits and risks of surgical and 
nonsurgical management of patients with PHPT. Some of 
the questions that could be addressed, as generated by 
the participants of the workshop, are given below. 
Patient's Questions 
• If I feel well now, how wil l I feel better after surgery? 
• How long before complications develop if I don't 
have surgery? 
• What will happen if I don't have surgery at all? 
Physician's Questions 
• What is the natural history of skeletal complications, 
and how is this history affected by surgery? 
• How does the cost of surgery compare to the cost of 
medical follow-up? 
• Are there factors present at the t ime of diagnosis that 
can predict the clinical course of the disease in an 
individual patient? 
• Do different forms of PHPT exist, and do these relate 
to the different secretory abnormalities (set-point 
change versus non-set-point change) or to different 
histologic abnormalities? 
• What is the success rate of surgery? 
• Are these complications reversible? 
• What constitutes cure? 
• Which surgeons should perform the initial 
parathyroidectomy? 
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• Which surgeons should perform fol low-up 
explorations? 
Serious concerns were raised about the feasibility of 
conduct ing such a trial. The best recognized, published 
prospective clinical trial of the management of PHPT 
was conducted at the Mayo Clinic (3). A principal inves-
tigator of that tr ial, Donald Scholz, reported at the 
workshop that the single l imit ing factor to the conduct 
of their trial was inadequate funding. Another major 
diff iculty encountered was the waning enthusiasm of 
the patient's primary care physician through the neces-
sarily long fo l low-up period. These concerns were 
echoed by many o f the participants. Without attempting 
to minimize these diff icult ies, it was agreed to proceed 
with the design of a clinical trial in order to better seek 
funding for such an undertaking. 
Discussion then concentrated on establishing a diag-
nosis of PHPT in a cost-effective manner. Table I contains 
the minimal criteria required to confirm PHPT. It also 
contains the parameters used to exclude nonparathyroid 
causes of hypercalcemia, such as sarcoidosis, milk-alkali 
syndrome, and various types of malignancy. Although 
some investigators had different operational definit ions, 
those present agreed to incorporate these criteria as the 
min imum guidelines for the proposed trial. Data which 
had been collected could always be excluded if not 
relevant, but data which had not been collected could 
never be assessed. 
The next issue addressed by the workshop participants 
was to determine which patients with PHPT could be 
ethically randomized into different treatment categories. 
TABLE I 
Min ima l Criteria to Diagnose PHPT and Exclude 
Nonparathyroid Causes of Hypercalcemia 
History and Physical Examination 
• Serum calcium greater than or equal to two standard deviations 
above the mean on more than one occasion (calcium measure-
ments can be either ionized or protein-corrected total serum 
calcium) 
• Mul t i -channel biochemical profi le 
• Complete blood count 
• Urinalysis 
• Chest radiograph 
• Serum and urine protein electrophoresis 
• Immunoreact ive PTH 
• 24-hour urine for calcium and creatinine 
• Intravenous pyelogram 
• T4, T3 if age greater than 70 
TABLE II 
Condit ions Mandat ing Parathyroidectomy if Present 
at Any Time 
Signs and Symptoms 
• Renal lithiasis 
• Clinically evident bone disease 
• Pancreatitis 
• Recurrent peptic ulcer disease 
• Disabling "so f t " PHPT-associated symptoms 
• Distance f rom medical care, making fo l low-up unlikely 
• Intercurrent thyroid surgery 
Laboratory Investigations 
• Serum calcium greater than 13 mg /DL on one occasion, greater 
than 12 mg/DL on two occasions, or greater than 11.5 mg/DL on 
three occasions. 
• Urinary calcium greater than 400 mg/24 hours on 750 mg calcium 
diet for 48 hours 
• Metabol ic bone disease (bone mineral content greater than two 
standard deviations below the mean) 
• Renal insufficiency 
• Anemia less than 10 gm hemoglob in /DL 
Patients with any of several serious conditions associated 
with hypercalcemia would be immediately moved into 
the surgical treatment group. Providing these patients 
with the usual treatment for hypercalcemia from PHPT 
(i.e., surgery) should protect them from possible detr i-
mental effects of the study. A list of the conditions that 
would mandate surgery is found in Table I I . 
Al though the major categories for randomization of 
appropriate patients were surgical and nonsurgical, 
interest was expressed in further subdividing the non-
surgical category. This would allow inclusion of other 
treatments also discussed at the Symposium, such as 
cimetidine, propanolol , estrogen, and diphosphanates, 
in addition to asimpleobservation group (Bilezikian, pp. 
159 ff.: Marcus, et al, pp. 162 ff.). The services ofa biosta-
tistician would be used to construct the overall experi-
mental design, and a determination would be made 
about the practicality of assessing the number of patients 
necessary to provide statistical significance with this 
increased number of treatment categories. 
The desirability of surgical input and especially stan-
dardization of the surgical approach was briefly dis-
cussed when it was announced that the American Asso-
ciation of Endocrine Surgeons (AAES) was interested in 
supporting this study. The consensus of the workshop 
participants was to leave further deliberations in this area 
to the AAES. Cont inued communication with this surgi-
cal organization was encouraged. 
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After four hours of discussion the workshop closed. A 
strong initiative was begun toevaluatecurrent treatment 
of PHPT, and a commitment was made to continue 
developing a protocol with which to seek proper fund-
ing. Individuals interested in participating in the design 
of this study were invited to contact the authors. 
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